Goodwin
Expertise
People
Careers
Legal
Paralegal
Science Advisor
Global Operations Team
Insights & Resources
About Us
Our Story
Diversity, Equity, and Inclusion
Pro Bono
Firm Leadership
Locations
News & Events
Alumni
Search by industry, practice, or name...
Insights & Resources
Search by topic, industry, practice, or person…
Practice
Select an option
Antitrust & Competition
Antitrust Services for Life Sciences Companies
Appellate and Supreme Court Litigation
Artificial Intelligence & Machine Learning
Asset Management Transactions
Banking
Brokers, Exchanges, and Trading
Business & Commercial Litigation
Buyouts & Acquisitions
Capital Markets
Class Actions
Clinical Trials Services
Complex Litigation & Dispute Resolution
Consumer Financial Services Enforcement & Government Investigations
Consumer Financial Services Litigation
Copyrights
Corporate Social Responsibility Law & Policy
Data, Privacy & Cybersecurity
Debt Capital Markets
Debt Finance
Derivatives
Digital Currency & Blockchain
Digital Health
Distressed Real Estate
Employment
Environmental
ERISA & Executive Compensation
ERISA Litigation
ESG & Impact
Fair & Responsible Lending
False Claims Act
FDA Litigation
Financial Restructuring
Financial Services Litigation
Fintech
Foreign Corrupt Practices Act
Fund Finance
Global Trade
Government Contracts & Grants
Government Investigations, Enforcement & White Collar Defense
Growth Equity
Hatch-Waxman, Biologics and Biosimilars Litigation
Healthcare Disputes & Investigations
Healthcare Private Equity
Healthcare Regulatory and Compliance
Intellectual Property
Intellectual Property Litigation
Investment Management Litigation
ITC 337 Proceedings
Late Stage Drug Development
Leasing
Life Sciences & Technology Arbitrations
Life Sciences Asia
Life Sciences Collaborations & Licensing
Life Sciences Emerging Companies
Life Sciences Europe
Life Sciences IPOs & Capital Markets
Life Sciences M&A
Life Sciences Patent Prosecution & Counseling
Life Sciences Regulatory & Compliance
Life Sciences Securities Litigation & Healthcare Fraud
Litigation
Mergers & Acquisitions
Metaverse
Mortgage Banking
New Company Formation
Operational Real Estate
Opinions & Counseling
Patent Litigation
Patent Prosecution & Counseling
Patent Trial & Appeal Board
Private Equity Asia
Private Equity France
Private Equity Germany
Private Equity UK
Products Litigation & Counseling
Public Company Advisory Practice
Real Estate Acquisitions & Dispositions
Real Estate Design & Construction
Real Estate Development & Permitting
Real Estate Dispute Resolution
Real Estate Finance & Restructuring
Real Estate Investment Funds
Real Estate Joint Ventures
Real Estate Tax
Risk Management & Insurance
Search Funds
Secondaries
Securities Litigation & SEC Enforcement
Securitization & Derivatives
Shareholder Activism & Takeover Defense
Special Purpose Acquisition Companies (SPACs)
State Attorneys General
Strategic Technology Transactions and Licensing
Tax
Technology Europe
Technology M&A
Trade Secrets, Employee Mobility & Non-Competes
Trademarks
Trusts & Estates
Venture Capital
Venture Capital & Private Equity Funds
Industry
Select an option
Cannabis
Climate Tech
Consumer Financial Services
Crowdfunding
Financial Services
Food & Healthy Living
Gaming & Gambling
Healthcare
Hedge Funds
Higher Education
Hospitality & Leisure
Industrial Technology & Advanced Manufacturing
Insurance
Insurtech
Investment Management
Life Sciences
Medtech
Open Source Software
Private Equity
Private Investment Funds
Proptech
Real Estate
REITs & Real Estate M&A
Tax-Exempt Organizations
Technology
Women's Health & Wellness
Location
Select an option
Boston
Cambridge
China
Frankfurt
Hong Kong
India
London
Los Angeles
Luxembourg
Munich
New York
Paris
San Francisco
Santa Monica
Silicon Valley
Washington, DC
Format
Select an option
Blog Posts
Case Studies
Newsletters
Publications
Date
Select an option
Past 30 Days
Past 90 Days
Past Year
Older Than One Year
Featured
Resource
Year-End Tool Kit
Resource
Corporate Transparency Act
Insight
November 13, 2024
Trends in Equity Repurchasing in PE: Rollover vs. Incentive Equity
Insight
November 19, 2024
Medtech M&A and Venture Investments Show Renewed Strength
Alert
November 7, 2024
Twenty Questions: Outbound Investment Security Program Targets China's Semiconductor, Quantum Computing, and AI Industries
See All
Resources
Understanding AI
Exhibit A: Charts on Legal and Market Trends
Corporate Transparency Act
Dobbs Task Force
See More
Blogs
Public Company Advisory Blog
Digital Currency & Blockchain Perspectives
Data, Privacy & Cybersecurity Insights
FinReg & Policy Watch
Life Sciences Perspectives
Big Molecule Watch
Consumer Finance Insights
Newsletters
Newsletter
Financial Services Weekly News Roundups
Newsletter
Securities Snapshot
Newsletter
Debt Download
Newsletter
ERISA Litigation Quarterly
